243 related articles for article (PubMed ID: 23926942)
1. Structure-activity relationship of flavonoids on their anti-Escherichia coli activity and inhibition of DNA gyrase.
Wu T; Zang X; He M; Pan S; Xu X
J Agric Food Chem; 2013 Aug; 61(34):8185-90. PubMed ID: 23926942
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
3. Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.
Verghese J; Nguyen T; Oppegard LM; Seivert LM; Hiasa H; Ellis KC
Bioorg Med Chem Lett; 2013 Nov; 23(21):5874-7. PubMed ID: 24060488
[TBL] [Abstract][Full Text] [Related]
4. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors.
Fang Y; Lu Y; Zang X; Wu T; Qi X; Pan S; Xu X
Sci Rep; 2016 Apr; 6():23634. PubMed ID: 27049530
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
Priyanka ; Singh V; Ekta ; Katiyar D
Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Salmonella Typhimurium DNA gyrase as a target of quinolones.
Kongsoi S; Yokoyama K; Suprasert A; Utrarachkij F; Nakajima C; Suthienkul O; Suzuki Y
Drug Test Anal; 2015 Aug; 7(8):714-20. PubMed ID: 25381884
[TBL] [Abstract][Full Text] [Related]
11. New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
Durcik M; Lovison D; Skok Ž; Durante Cruz C; Tammela P; Tomašič T; Benedetto Tiz D; Draskovits G; Nyerges Á; Pál C; Ilaš J; Peterlin Mašič L; Kikelj D; Zidar N
Eur J Med Chem; 2018 Jun; 154():117-132. PubMed ID: 29778894
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
Abdullah MI; Mahmood A; Madni M; Masood S; Kashif M
Bioorg Chem; 2014 Jun; 54():31-7. PubMed ID: 24747187
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL
Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266
[TBL] [Abstract][Full Text] [Related]
14. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones.
Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y
J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity.
Trzoss M; Bensen DC; Li X; Chen Z; Lam T; Zhang J; Creighton CJ; Cunningham ML; Kwan B; Stidham M; Nelson K; Brown-Driver V; Castellano A; Shaw KJ; Lightstone FC; Wong SE; Nguyen TB; Finn J; Tari LW
Bioorg Med Chem Lett; 2013 Mar; 23(5):1537-43. PubMed ID: 23294697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]